Ask AI

The APP Advantage: Optimizing BCMA- and GPRC5D-Directed Bispecific Antibody Care in Multiple Myeloma

Slideset

Released: September 18, 2026

See Activity Collection

Download slides from a live webinar to gain expert perspectives on the role of APPs in managing patients with multiple myeloma receiving bispecific antibody therapy.

BsAbs for MM for APPs

Activity Information

Released: September 18, 2026